WBO:BIO (Austria)  
Biogena Group Invest AG logo

Biogena Group Invest AG

€ 1.86 (0%) Sep 28
P/E:
10.11
P/B:
0.86
Market Cap:
€ 7.42M ($ 7.19M)
Enterprise V:
€ 7.40M ($ 7.17M)
Volume:
830.00
Avg Vol (2M):
2.29K
Volume:
830.00
Market Cap €:
7.42M
Market Cap $:
7.19M
PE Ratio:
10.11
Avg Vol (2-Month):
2.29K
Enterprise Value €:
7.40M
Enterprise Value $:
7.17M
PB Ratio:
0.86
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.99
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 45.96
9-Day RSI 42.89
14-Day RSI 40.81
6-1 Month Momentum % -28.99
12-1 Month Momentum % -27.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 24.31
Quick Ratio 24.31
Cash Ratio 0.33
Days Sales Outstanding 786.24
Days Payable 9125

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 5.38
Dividend Payout Ratio 0.22
Forward Dividend Yield % 5.38
5-Year Yield-on-Cost % 5.38

Financials

WBO:BIO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.331
EPS (TTM) (€) 0.184
Beta 0
Volatility % 32.07
14-Day RSI 40.81
14-Day ATR (€) 0.038434
20-Day SMA (€) 1.8665
12-1 Month Momentum % -27.41
52-Week Range (€) 1.79 - 3.15
Shares Outstanding (Mil) 3.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biogena Group Invest AG Filings

Document Form Filing Date
No Filing Data

Biogena Group Invest AG Analysis

Share your research